PSMA-11

• Description:

  PSMA-11 (HBED-CC-PSMA) detects prostate cancer recurrence and metastasis by binding to the extracellular structural domain of prostate-specific membrane antigen (PSMA) .PSMA-11 is often used as a tracer of PSMA-expressing tumours in positron emission tomography (PET) scanning by intravenous injection of gallium Ga 68-labelled PSMA-11, Glu-urea-Lys (Ahx) molecule targeted and bound PSMA-expressing tumour cells. After internalisation, PSMA-expressing tumour cells could be detected on PET imaging.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  946.99

• Molecular Formula:

  C44H62N6O17

• Notes:

  Research use only, not for human use.

• Receptor:

  PSMA

• CAS Number:

  1366302-52-4